CD163 and ovarian carcinoma: Although we focused on the analysis of breast cancer data, higher CD163+ TAM density has been shown to be correlated with worse prognosis in other cancer subtypes such as cutaneous melanoma [57], colorectal carcinoma [58,59], and ovarian carcinoma [60].